Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Felberbaum

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Human Reproduction (Oxford, England)|February 19, 2008
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHREA Nyboe Andersen, V Goossens, A P Ferraretti, et al.
Journal of Assisted Reproduction and Genetics|March 1, 1996
Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosagesR Felberbaum, T Reissmann, W Küpker, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized studyM Ludwig, P Schwartz, B Babahan, et al.
European Journal of Endocrinology|May 29, 2001
Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cellsJ M Weiss, K Oltmanns, E M Gürke, et al.
Journal of Assisted Reproduction and Genetics|November 6, 2004
FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulationG Griesinger, D Finas, A Alisch, et al.
Human Reproduction (Oxford, England)|January 25, 2005
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocolG Griesinger, A Schultze-Mosgau, K Dafopoulos, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 23, 2000
Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonistsN Nikolettos, S Al-Hasani, R Felberbaum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2022
Financial difficulties in breast cancer survivors with and without migration background in Germany-results from the prospective multicentre cohort study BRENDA IIN Riccetti, R Felberbaum, F Flock, et al.
Zentralblatt Fur Gynakologie|November 25, 2003
[Cumulus cell apoptosis as a predictor for oocyte quality in artificial reproduction technique]A Alisch, K Rüping, F Köster, et al.
Human Reproduction (Oxford, England)|November 26, 1999
Fertilization potential of spermatozoa with abnormal morphologyN Nikolettos, W Küpker, C Demirel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Human Reproduction (Oxford, England)|February 19, 2008
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHREA Nyboe Andersen, V Goossens, A P Ferraretti, et al.
Journal of Assisted Reproduction and Genetics|March 1, 1996
Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosagesR Felberbaum, T Reissmann, W Küpker, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized studyM Ludwig, P Schwartz, B Babahan, et al.
European Journal of Endocrinology|May 29, 2001
Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cellsJ M Weiss, K Oltmanns, E M Gürke, et al.
Journal of Assisted Reproduction and Genetics|November 6, 2004
FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulationG Griesinger, D Finas, A Alisch, et al.
Human Reproduction (Oxford, England)|January 25, 2005
Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocolG Griesinger, A Schultze-Mosgau, K Dafopoulos, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 23, 2000
Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonistsN Nikolettos, S Al-Hasani, R Felberbaum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2022
Financial difficulties in breast cancer survivors with and without migration background in Germany-results from the prospective multicentre cohort study BRENDA IIN Riccetti, R Felberbaum, F Flock, et al.
Zentralblatt Fur Gynakologie|November 25, 2003
[Cumulus cell apoptosis as a predictor for oocyte quality in artificial reproduction technique]A Alisch, K Rüping, F Köster, et al.
Human Reproduction (Oxford, England)|November 26, 1999
Fertilization potential of spermatozoa with abnormal morphologyN Nikolettos, W Küpker, C Demirel, et al.
Pageof 5